VICTOR AIRE-OAIHIMIRE: Open Payments
NPI 1912158551 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 8 companies in 2025. Trend: 2023 $196 · 2024 $122 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| bioMerieux Inc | 1 | $35 |
| Dexcom, Inc. | 1 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $27 |
| PFIZER INC. | 1 | $21 |
| Phadia US Inc. | 1 | $18 |
| Amgen Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: CAPLYTA, Dexcom G6 Transmitter, LifeVest, PAXLOVID, ImmunoCAP, OTEZLA, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
